Beneficial Effect of Angiotensin-Converting Enzyme Inhibitor on Dilated Cardiomyopathy Induced by Autoimmune Mechanism Against β1-Adrenoceptor

Autor: Takayuki Kurihara, T Katsuda, H Wakabayashi, Shinobu Matsui, Noboru Takekoshi, Nobuo Yamaguchi, Kohei Teraoka, Michael Fu, Mituru Hayase
Rok vydání: 2000
Předmět:
Zdroj: Journal of Cardiovascular Pharmacology. 36:S43-S48
ISSN: 0160-2446
DOI: 10.1097/00005344-200000006-00010
Popis: We have shown that a peptide corresponding to the sequence of the second extracellular loop of the human beta1-adrenoceptor (beta1-peptide) was able to induce an autoimmune cardiomyopathy in rabbits. In this study, we examined the effect of angiotensin-converting enzyme inhibitor (ACEI) on beta1-peptide-induced cardiomyopathy. Rabbits were divided into four groups: (1) control group (n= 6) receiving saline injection; (2) beta1-peptide group (n = 8) immunized with beta1-peptide; (3) ACEI group (n = 6), lisinopril (3 mg/day) given orally and receiving saline injection; and (4) ACEI + beta1-peptide group (n = 7), lisinopril (3 mg/day) given orally and immunized with beta1-peptide. Our results showed that, after 1 year, all rabbits in the beta1-peptide group had an increase in heart weight, wall thinning and dilatations of both ventricles as compared with rabbits in the ACEI + beta1-peptide group that had normal heart weight and shape. All rabbits in the beta1-peptide group exhibited multifocal degeneration and necrosis of myocardial cells with moderate infiltration of inflammatory cells. In the ACEI + beta1-peptide group, three rabbits showed focal degeneration and necrosis of myocardial cells accompanied by mononuclear cells. The lesions in this group were apparently less marked than those in the beta1-peptide group. In conclusion, ACEI protects the myocardium from injury induced by an autoimmune mechanism against beta1-adrenoceptor.
Databáze: OpenAIRE